Wave Life Sciences, Inc. (WVE)
4.86
+0.16
(+3.40%)
USD |
NASDAQ |
Sep 04, 16:00
4.855
0.00 (0.00%)
After-Hours: 20:00
Wave Life Sciences Shareholders Equity (Quarterly) : 453.52M for June 30, 2026
Shareholders Equity (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Shareholders Equity (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 453.52M |
| March 31, 2026 | 511.73M |
| December 31, 2025 | 526.23M |
| September 30, 2025 | 132.42M |
| June 30, 2025 | 147.14M |
| March 31, 2025 | 179.68M |
| December 31, 2024 | 217.39M |
| September 30, 2024 | 149.51M |
| June 30, 2024 | 4.397M |
| March 31, 2024 | 33.26M |
| December 31, 2023 | 47.50M |
| September 30, 2023 | -32.61M |
| June 30, 2023 | -43.85M |
| March 31, 2023 | -26.84M |
| December 31, 2022 | -37.22M |
| September 30, 2022 | 3.355M |
| June 30, 2022 | 38.82M |
| March 31, 2022 | 7.821M |
| December 31, 2021 | 40.37M |
| September 30, 2021 | 37.78M |
| June 30, 2021 | 29.72M |
| March 31, 2021 | 60.70M |
| Date | Value |
|---|---|
| December 31, 2020 | 90.65M |
| September 30, 2020 | 116.12M |
| June 30, 2020 | 3.385M |
| March 31, 2020 | 28.73M |
| December 31, 2019 | 71.61M |
| September 30, 2019 | 122.65M |
| June 30, 2019 | 168.10M |
| March 31, 2019 | 204.73M |
| December 31, 2018 | 81.22M |
| September 30, 2018 | 114.48M |
| June 30, 2018 | 147.17M |
| March 31, 2018 | 117.92M |
| December 31, 2017 | 147.48M |
| September 30, 2017 | 173.73M |
| June 30, 2017 | 188.91M |
| March 31, 2017 | 124.96M |
| December 31, 2016 | 142.74M |
| September 30, 2016 | 159.01M |
| June 30, 2016 | 174.15M |
| March 31, 2016 | 154.40M |
| December 31, 2015 | 161.36M |
| September 30, 2015 | -3.12M |
Shareholders' Equity Definition
Represents the value of Shareholders' Equity as of the close of the report date, belonging to both Preferred and Common Equity Shareholders.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| Filana Therapeutics, Inc. | 63.61M |
| CorMedix, Inc. | 460.83M |
| Eloxx Pharmaceuticals, Inc. | 46.42M |
| Cannabis Global, Inc. | -4.772M |
| Breakthrough Chemistry, Inc. | 0.8373M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 558.32M |
| Total Liabilities (Quarterly) | 104.80M |
| Debt to Equity Ratio | 0.0961 |
| Current Ratio | 9.987 |
| Net Debt Paydown Yield | -0.36% |